Call for papers: Developmental epigenetics

The editors at Communications Biology now invite mechanistic studies that advance understanding of epigenetic regulation in development using in vivo systems, organoids, or other model systems. Submissions are encouraged by 29 January 2027.
Call for papers: Developmental epigenetics
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

What is this collection about?

Developmental epigenetics examines how chromatin states, DNA methylation patterns, histone modifications, and three dimensional genome architecture are established, maintained, and remodeled to govern cell fate decisions over developmental time.

Recent advances in single cell and spatial genomics, embryo research, and stem cell–based models have revealed that epigenetic regulation can shape lineage commitment, developmental timing, and cellular plasticity. These studies show that epigenetic states integrate intrinsic transcriptional programs with signalling, metabolic, and environmental inputs, and that disruption of these processes underlies developmental abnormalities and long term disease risk.

The editors at Communications Biology now invite mechanistic studies that advance understanding of epigenetic regulation in development using in vivo systems, organoids, or other model systems. We will mainly consider original research Articles but Reviews, and Perspectives are also welcome.

Why submit to a collection?

Collections like this one help promote high-quality science. They are led by professional In-House Editors (and sometimes expert Guest Editors) and supported by a dedicated team of Commissioning Editors and Managing Editors at Springer Nature. Collection manuscripts typically see higher citations, downloads, and Altmetric scores, and provide a one-stop-shop on a cutting-edge topic of interest.

This Collection welcomes submissions from all authors – and not by invitation only – on the condition that the manuscripts fall within the scope of the Collection and of Communications Biology more generally. See our editorial process page for more details. All manuscripts published in the collection are hosted on a dedicated nature portfolio portal, giving articles high visibility beyond the journal they are published in.

Who is involved?

Communications Biology is edited by both in-house professional editors and Editorial Board Members.

Our editors work closely together to ensure the quality of our published papers and consistency in author experience.

How can I submit my paper?

Visit the Collection page to find out more about this collection and submit your article.

 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Epigenetics
Life Sciences > Biological Sciences > Genetics and Genomics > Epigenetics
Epigenetic Memory
Life Sciences > Biological Sciences > Developmental Biology and Stem Cells > Stem Cell Biology > Epigenetic Memory
Epigenetics
Life Sciences > Biological Sciences > Molecular Biology > Epigenetics

Related Collections

With Collections, you can get published faster and increase your visibility.

Healthy Aging

This collection welcomes submissions based on studying preclinical models, as well as population-wide and clinical studies. Studies that advance our understanding of mechanisms behind healthy aging are also welcomed. Clinical research of interest will include epidemiological studies, observational studies, longitudinal cohort studies, systematic reviews and clinical trials.

Publishing Model: Open Access

Deadline: Dec 31, 2026

Cell death and inflammatory signalling

The editor invite submissions of original biological and clinical research focusing on the finely-tuned control of non-immune and immune cell death, the coordinated regulation of programmed cell death and the resulted immune response in health and disease, and the selective targeting of cell death regulatory molecules as a therapeutic solution for chronic inflammatory disorders.

Publishing Model: Hybrid

Deadline: Oct 28, 2026